ArticleCancer control : journal of the Moffitt Cancer Center

DDR1 is a Novel Biomarker and Potential Therapeutic Target for the Combination Treatment of Liver Hepatocellular Carcinoma.

Tianxing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.